David Diemert
Professor of Medicine, of Microbiology, Immunology, and Tropical Medicine, and of Epidemiology · George Washington University School of Medicine
Credentials: · · ·
History
Infectious Disease
Internal Medicine
Research
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
New England Journal of Medicine · 2021 · 8,425 citations
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm
Review · The Lancet · 2006 · 1,557 citations
Vaccination induces HIV broadly neutralizing antibody precursors in humans
Science · 2022 · 256 citations
- NR
14 papers
12 papers
- RA
12 papers
12 papers
11 papers
- EM
11 papers
- JW
11 papers
11 papers
Grants
- 2025–2026
Planning for Na-GST-1 Hookworm Vaccine Phase 2 CHIM Efficacy Trial
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $242.1K · George Washington University
- 2017–2024
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $3.6M · George Washington University
- 2015–2019
Phase 1 Trial of Na-APR-1 and Na-GST-1 Hookworm Vaccines in Brazilian Adults
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.2M · George Washington University
- 2015–2016
Planning for Experimental Infection Trial to Test Hookworm Vaccine Efficacy
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $161K · George Washington University
Clinical trials
- 2020–2023
Principal investigator · Completed · Phase 1
International AIDS Vaccine Initiative
- 2018–2025
Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
Principal investigator · Completed · Phase 2
Baylor College of Medicine
- 2016–2017
Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults
Principal investigator · Completed · Phase 1
Baylor College of Medicine
- 2015–2027
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine